SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages

Several lines of evidence have suggested that protein tyrosine phosphatases, including CD45 and SHP-1, regulate macrophage activation. Macrophages from mice lacking SHP-1 (motheaten mice) are hyper-responsive to many stimuli, suggesting that SHP-1 may negatively regulate macrophage activation. Herei...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2006-04, Vol.342 (2), p.547-555
Hauptverfasser: Hardin, Amy O., Meals, Elizabeth A., Yi, Taolin, Knapp, Katherine M., English, B. Keith
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 555
container_issue 2
container_start_page 547
container_title Biochemical and biophysical research communications
container_volume 342
creator Hardin, Amy O.
Meals, Elizabeth A.
Yi, Taolin
Knapp, Katherine M.
English, B. Keith
description Several lines of evidence have suggested that protein tyrosine phosphatases, including CD45 and SHP-1, regulate macrophage activation. Macrophages from mice lacking SHP-1 (motheaten mice) are hyper-responsive to many stimuli, suggesting that SHP-1 may negatively regulate macrophage activation. Herein we report that the repressible/inducible over-expression of wild-type SHP-1 in a subclone of RAW 264.7 macrophages (RAW-TT10 cells) inhibited both TNF secretion and iNOS protein accumulation in response to stimulation with lipopolysaccharide (LPS) and recombinant murine interferon-gamma and led to diminished LPS-mediated tyrosine phosphorylation of vav1. In contrast, expression of a truncated SHP-1 construct previously shown to interfere with endogenous SHP-1 function modestly augmented LPS-mediated TNF and iNOS production and did not inhibit vav1 tyrosine phosphorylation. Taken together, these data provide the first direct evidence that SHP-1 inhibits macrophage activation by LPS and suggest that this effect may be mediated in part by dephosphorylation of vav1.
doi_str_mv 10.1016/j.bbrc.2006.02.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67694618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X06002889</els_id><sourcerecordid>17106289</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-9ff90e5a6423d02499b4a84b49c690feb78d51c00ea9cd781142e1a33211bfad3</originalsourceid><addsrcrecordid>eNqFkMFqGzEQhkVpqN0kL9BD2VNvu5nRytoV9FJM0hhMEnACuQmtNFvLeHddabfQt6-MDb0lpznM9__MfIx9QSgQUN7siqYJtuAAsgBeACw-sDmCgpwjiI9sDmmTc4WvM_Y5xh0AopDqE5uhFHWlSj5nq839U46Z77e-8WPM1k-bvCPnzUgue364y0zvMv_wuMkOYXCTHf3QJzrrpuB7yjpjw3DYml8Ur9hFa_aRrs_zkr3c3T4v7_P148_V8sc6t2W9GHPVtgpoYaTgpQMulGqEqUUjlJUKWmqq2i3QApBR1lV1OpkTmrLkiE1rXHnJvp1600G_J4qj7ny0tN-bnoYpallJJSTW74JYIUheqwTyE5h-iTFQqw_Bdyb81Qj6aFrv9NG0PprWwHUynUJfz-1Tk4T9j5zVJuD7CaAk44-noKP11NskN5AdtRv8W_3_AP_wjT4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17106289</pqid></control><display><type>article</type><title>SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hardin, Amy O. ; Meals, Elizabeth A. ; Yi, Taolin ; Knapp, Katherine M. ; English, B. Keith</creator><creatorcontrib>Hardin, Amy O. ; Meals, Elizabeth A. ; Yi, Taolin ; Knapp, Katherine M. ; English, B. Keith</creatorcontrib><description>Several lines of evidence have suggested that protein tyrosine phosphatases, including CD45 and SHP-1, regulate macrophage activation. Macrophages from mice lacking SHP-1 (motheaten mice) are hyper-responsive to many stimuli, suggesting that SHP-1 may negatively regulate macrophage activation. Herein we report that the repressible/inducible over-expression of wild-type SHP-1 in a subclone of RAW 264.7 macrophages (RAW-TT10 cells) inhibited both TNF secretion and iNOS protein accumulation in response to stimulation with lipopolysaccharide (LPS) and recombinant murine interferon-gamma and led to diminished LPS-mediated tyrosine phosphorylation of vav1. In contrast, expression of a truncated SHP-1 construct previously shown to interfere with endogenous SHP-1 function modestly augmented LPS-mediated TNF and iNOS production and did not inhibit vav1 tyrosine phosphorylation. Taken together, these data provide the first direct evidence that SHP-1 inhibits macrophage activation by LPS and suggest that this effect may be mediated in part by dephosphorylation of vav1.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2006.02.005</identifier><identifier>PMID: 16487932</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cell Line ; Cells, Cultured ; Clone Cells ; Cytokine ; Enzyme Inhibitors - pharmacology ; iNOS ; Interferon-gamma - pharmacology ; Intracellular Signaling Peptides and Proteins - physiology ; Kinase ; Lipopolysaccharides - pharmacology ; Macrophage ; Macrophage Activation - immunology ; Macrophages - enzymology ; Macrophages - immunology ; Mice ; Nitric Oxide Synthase Type II - antagonists &amp; inhibitors ; Nitric Oxide Synthase Type II - biosynthesis ; Phosphatase ; Phosphorylation ; Protein Tyrosine Phosphatase, Non-Receptor Type 6 ; Protein Tyrosine Phosphatases - physiology ; Proto-Oncogene Proteins c-vav - antagonists &amp; inhibitors ; Proto-Oncogene Proteins c-vav - metabolism ; Recombinant Proteins ; SHP-1 ; Signal transduction ; Tetracycline - pharmacology ; TNF ; Transfection ; Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors ; Tumor Necrosis Factor-alpha - biosynthesis ; Tyrosine</subject><ispartof>Biochemical and biophysical research communications, 2006-04, Vol.342 (2), p.547-555</ispartof><rights>2006 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-9ff90e5a6423d02499b4a84b49c690feb78d51c00ea9cd781142e1a33211bfad3</citedby><cites>FETCH-LOGICAL-c385t-9ff90e5a6423d02499b4a84b49c690feb78d51c00ea9cd781142e1a33211bfad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbrc.2006.02.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16487932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hardin, Amy O.</creatorcontrib><creatorcontrib>Meals, Elizabeth A.</creatorcontrib><creatorcontrib>Yi, Taolin</creatorcontrib><creatorcontrib>Knapp, Katherine M.</creatorcontrib><creatorcontrib>English, B. Keith</creatorcontrib><title>SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Several lines of evidence have suggested that protein tyrosine phosphatases, including CD45 and SHP-1, regulate macrophage activation. Macrophages from mice lacking SHP-1 (motheaten mice) are hyper-responsive to many stimuli, suggesting that SHP-1 may negatively regulate macrophage activation. Herein we report that the repressible/inducible over-expression of wild-type SHP-1 in a subclone of RAW 264.7 macrophages (RAW-TT10 cells) inhibited both TNF secretion and iNOS protein accumulation in response to stimulation with lipopolysaccharide (LPS) and recombinant murine interferon-gamma and led to diminished LPS-mediated tyrosine phosphorylation of vav1. In contrast, expression of a truncated SHP-1 construct previously shown to interfere with endogenous SHP-1 function modestly augmented LPS-mediated TNF and iNOS production and did not inhibit vav1 tyrosine phosphorylation. Taken together, these data provide the first direct evidence that SHP-1 inhibits macrophage activation by LPS and suggest that this effect may be mediated in part by dephosphorylation of vav1.</description><subject>Animals</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>Clone Cells</subject><subject>Cytokine</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>iNOS</subject><subject>Interferon-gamma - pharmacology</subject><subject>Intracellular Signaling Peptides and Proteins - physiology</subject><subject>Kinase</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Macrophage</subject><subject>Macrophage Activation - immunology</subject><subject>Macrophages - enzymology</subject><subject>Macrophages - immunology</subject><subject>Mice</subject><subject>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</subject><subject>Nitric Oxide Synthase Type II - biosynthesis</subject><subject>Phosphatase</subject><subject>Phosphorylation</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 6</subject><subject>Protein Tyrosine Phosphatases - physiology</subject><subject>Proto-Oncogene Proteins c-vav - antagonists &amp; inhibitors</subject><subject>Proto-Oncogene Proteins c-vav - metabolism</subject><subject>Recombinant Proteins</subject><subject>SHP-1</subject><subject>Signal transduction</subject><subject>Tetracycline - pharmacology</subject><subject>TNF</subject><subject>Transfection</subject><subject>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><subject>Tyrosine</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFqGzEQhkVpqN0kL9BD2VNvu5nRytoV9FJM0hhMEnACuQmtNFvLeHddabfQt6-MDb0lpznM9__MfIx9QSgQUN7siqYJtuAAsgBeACw-sDmCgpwjiI9sDmmTc4WvM_Y5xh0AopDqE5uhFHWlSj5nq839U46Z77e-8WPM1k-bvCPnzUgue364y0zvMv_wuMkOYXCTHf3QJzrrpuB7yjpjw3DYml8Ur9hFa_aRrs_zkr3c3T4v7_P148_V8sc6t2W9GHPVtgpoYaTgpQMulGqEqUUjlJUKWmqq2i3QApBR1lV1OpkTmrLkiE1rXHnJvp1600G_J4qj7ny0tN-bnoYpallJJSTW74JYIUheqwTyE5h-iTFQqw_Bdyb81Qj6aFrv9NG0PprWwHUynUJfz-1Tk4T9j5zVJuD7CaAk44-noKP11NskN5AdtRv8W_3_AP_wjT4</recordid><startdate>20060407</startdate><enddate>20060407</enddate><creator>Hardin, Amy O.</creator><creator>Meals, Elizabeth A.</creator><creator>Yi, Taolin</creator><creator>Knapp, Katherine M.</creator><creator>English, B. Keith</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20060407</creationdate><title>SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages</title><author>Hardin, Amy O. ; Meals, Elizabeth A. ; Yi, Taolin ; Knapp, Katherine M. ; English, B. Keith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-9ff90e5a6423d02499b4a84b49c690feb78d51c00ea9cd781142e1a33211bfad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>Clone Cells</topic><topic>Cytokine</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>iNOS</topic><topic>Interferon-gamma - pharmacology</topic><topic>Intracellular Signaling Peptides and Proteins - physiology</topic><topic>Kinase</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Macrophage</topic><topic>Macrophage Activation - immunology</topic><topic>Macrophages - enzymology</topic><topic>Macrophages - immunology</topic><topic>Mice</topic><topic>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</topic><topic>Nitric Oxide Synthase Type II - biosynthesis</topic><topic>Phosphatase</topic><topic>Phosphorylation</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 6</topic><topic>Protein Tyrosine Phosphatases - physiology</topic><topic>Proto-Oncogene Proteins c-vav - antagonists &amp; inhibitors</topic><topic>Proto-Oncogene Proteins c-vav - metabolism</topic><topic>Recombinant Proteins</topic><topic>SHP-1</topic><topic>Signal transduction</topic><topic>Tetracycline - pharmacology</topic><topic>TNF</topic><topic>Transfection</topic><topic>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><topic>Tyrosine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hardin, Amy O.</creatorcontrib><creatorcontrib>Meals, Elizabeth A.</creatorcontrib><creatorcontrib>Yi, Taolin</creatorcontrib><creatorcontrib>Knapp, Katherine M.</creatorcontrib><creatorcontrib>English, B. Keith</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hardin, Amy O.</au><au>Meals, Elizabeth A.</au><au>Yi, Taolin</au><au>Knapp, Katherine M.</au><au>English, B. Keith</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2006-04-07</date><risdate>2006</risdate><volume>342</volume><issue>2</issue><spage>547</spage><epage>555</epage><pages>547-555</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Several lines of evidence have suggested that protein tyrosine phosphatases, including CD45 and SHP-1, regulate macrophage activation. Macrophages from mice lacking SHP-1 (motheaten mice) are hyper-responsive to many stimuli, suggesting that SHP-1 may negatively regulate macrophage activation. Herein we report that the repressible/inducible over-expression of wild-type SHP-1 in a subclone of RAW 264.7 macrophages (RAW-TT10 cells) inhibited both TNF secretion and iNOS protein accumulation in response to stimulation with lipopolysaccharide (LPS) and recombinant murine interferon-gamma and led to diminished LPS-mediated tyrosine phosphorylation of vav1. In contrast, expression of a truncated SHP-1 construct previously shown to interfere with endogenous SHP-1 function modestly augmented LPS-mediated TNF and iNOS production and did not inhibit vav1 tyrosine phosphorylation. Taken together, these data provide the first direct evidence that SHP-1 inhibits macrophage activation by LPS and suggest that this effect may be mediated in part by dephosphorylation of vav1.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>16487932</pmid><doi>10.1016/j.bbrc.2006.02.005</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2006-04, Vol.342 (2), p.547-555
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_67694618
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Cell Line
Cells, Cultured
Clone Cells
Cytokine
Enzyme Inhibitors - pharmacology
iNOS
Interferon-gamma - pharmacology
Intracellular Signaling Peptides and Proteins - physiology
Kinase
Lipopolysaccharides - pharmacology
Macrophage
Macrophage Activation - immunology
Macrophages - enzymology
Macrophages - immunology
Mice
Nitric Oxide Synthase Type II - antagonists & inhibitors
Nitric Oxide Synthase Type II - biosynthesis
Phosphatase
Phosphorylation
Protein Tyrosine Phosphatase, Non-Receptor Type 6
Protein Tyrosine Phosphatases - physiology
Proto-Oncogene Proteins c-vav - antagonists & inhibitors
Proto-Oncogene Proteins c-vav - metabolism
Recombinant Proteins
SHP-1
Signal transduction
Tetracycline - pharmacology
TNF
Transfection
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Tumor Necrosis Factor-alpha - biosynthesis
Tyrosine
title SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T07%3A59%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SHP-1%20inhibits%20LPS-mediated%20TNF%20and%20iNOS%20production%20in%20murine%20macrophages&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Hardin,%20Amy%20O.&rft.date=2006-04-07&rft.volume=342&rft.issue=2&rft.spage=547&rft.epage=555&rft.pages=547-555&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2006.02.005&rft_dat=%3Cproquest_cross%3E17106289%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17106289&rft_id=info:pmid/16487932&rft_els_id=S0006291X06002889&rfr_iscdi=true